SORRENTINO, CLAUDIA

SORRENTINO, CLAUDIA  

Dipartimento di Farmacia/DIFARMA  

Mostra records
Risultati 1 - 12 di 12 (tempo di esecuzione: 0.036 secondi).
Titolo Data di pubblicazione Autore(i) File
Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression. 1-gen-2016 Sorrentino, Claudia; Miele, Lucio; Porta, Amalia; Pinto, Aldo; Morello, Silvana
Adenosine A2A Receptor Stimulation Inhibits TCR-Induced Notch1 Activation in CD8+T-Cells 1-gen-2019 Sorrentino, Claudia; Hossain, Fokhrul; Rodriguez, Paulo C.; Sierra, Rosa A.; Pannuti, Antonio; Osborne, Barbara A.; Minter, Lisa M.; Miele, Lucio; Morello, Silvana
Expression of CD73 on CD8+/PD-1+cells as a new possible biomarker for advanced melanoma patients treated with nivolumab 1-gen-2018 Fratangelo, Federica; Morello, Silvana; Madonna, Gabriele; Elena Capone, Maria; Mallardo, Domenico; Falcone, Rosaria; Grimaldi, Antonio M.; Simeone, Ester; Vanella, Vito; Giannarelli, Diana; Sorrentino, Claudia; Pinto, Aldo; Ascierto, Paolo A.
Expression of CD73 on MDSCs and CD8+/PD-1+cells as new possible biomarkers for advanced melanoma patients treated with nivolumab 1-gen-2018 Fratangelo, F; Morello, S; Madonna, G; Capone, M; Mallardo, D; Falcone, R; Grimaldi, Am; Simeone, E; Vanella, V; Giannarelli, D; Sorrentino, C; Pinto, A; Ascierto, Pa
Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients 1-gen-2020 Capone, M.; Fratangelo, F.; Giannarelli, D.; Sorrentino, C.; Turiello, R.; Zanotta, S.; Galati, D.; Madonna, G.; Tuffanelli, M.; Scarpato, L.; Grimaldi, A. M.; Esposito, A.; Azzaro, R.; Pinto, A.; Cavalcanti, E.; Pinto, A.; Morello, S.; Ascierto, P. A.
Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model 1-gen-2015 Sorrentino, Claudia; Miele, Lucio; Porta, Amalia; Pinto, Aldo; Morello, Silvana
Notch Signaling Regulates Mitochondrial Metabolism and NF-kappa B Activity in Triple-Negative Breast Cancer Cells via IKK alpha-Dependent Non-canonical Pathways 1-gen-2018 Hossain, F; Sorrentino, Claudia; Ucar, Da; Peng, Y; Matossian, M; Wyczechowska, D; Crabtree, J; Zabaleta, J; Morello, S; Del Valle, L; Burow, M; Collins-Burow, B; Pannuti, A; Minter, Lm; Golde, Te; Osborne, Ba; Miele, L.
Role of adenosine in tumor progression: focus on A2B receptor as potential therapeutic target 1-gen-2017 Sorrentino, Claudia; Morello, Silvana
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab 1-gen-2017 Morello, Silvana; Capone, Mariaelena; Sorrentino, Claudia; Giannarelli, Diana; Madonna, Gabriele; Mallardo, Domenico; Grimaldi, Antonio M.; Pinto, Aldo; Ascierto, Paolo Antonio
Soluble CD73 in the peripheral blood: a potential biomarker in patients with advanced melanoma receiving nivolumab 1-gen-2018 Morello, Silvana; Elena Capone, Maria; Sorrentino, Claudia; Giannarelli, Diana; Madonna, Gabriele; Mallardo, Domenico; M Grimaldi, Antonio; Pinto, Aldo; Antonio Ascierto, Paolo
Targeting adenosine A2b receptor reduces melanoma progression in mice: role of tumor-associated MDSCs 1-gen-2014 Morello, Silvana; Teresa, Loffredo Maria; Sorrentino, Claudia; Pinto, Aldo
The A2B adenosine receptor: an emerging therapeutic target in cancer 1-gen-2017 Morello, Silvana; Sorrentino, Claudia; Pinto, Aldo